Literature DB >> 25596262

Mutations of ASXL1 and TET2 in aplastic anemia.

Jinbo Huang1, Meili Ge1, Shihong Lu1, Jun Shi1, Xingxin Li1, Jizhou Zhang1, Min Wang1, Wei Yu1, Yingqi Shao1, Zhendong Huang1, Jing Zhang1, Neng Nie1, Yizhou Zheng2.   

Abstract

Entities:  

Keywords:  ASXL1; TET2; aplastic anemia

Mesh：

Substances：

Year:  2015        PMID： 25596262      PMCID： PMC4420224          DOI： 10.3324/haematol.2014.120931

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  15 in total

Review 1.  Guidelines for the diagnosis and management of aplastic anaemia.

Authors:  Judith C W Marsh; Sarah E Ball; Jamie Cavenagh; Phil Darbyshire; Inderjeet Dokal; Edward C Gordon-Smith; Jane Keidan; Andrew Laurie; Anna Martin; Jane Mercieca; Sally B Killick; Rhona Stewart; John A L Yin
Journal:  Br J Haematol       Date:  2009-08-10       Impact factor: 6.998

2.  Frequent mutation of the polycomb-associated gene ASXL1 in the myelodysplastic syndromes and in acute myeloid leukemia.

Authors:  J Boultwood; J Perry; A Pellagatti; M Fernandez-Mercado; C Fernandez-Santamaria; M J Calasanz; M J Larrayoz; M Garcia-Delgado; A Giagounidis; L Malcovati; M G Della Porta; M Jädersten; S Killick; E Hellström-Lindberg; M Cazzola; J S Wainscoat
Journal:  Leukemia       Date:  2010-02-25       Impact factor: 11.528

3.  Antithymocyte globulin and cyclosporine for severe aplastic anemia: association between hematologic response and long-term outcome.

Authors:  Stephen Rosenfeld; Dean Follmann; Olga Nunez; Neal S Young
Journal:  JAMA       Date:  2003-03-05       Impact factor: 56.272

4.  TET2 mutation is an independent favorable prognostic factor in myelodysplastic syndromes (MDSs).

Authors:  Olivier Kosmider; Véronique Gelsi-Boyer; Meyling Cheok; Sophie Grabar; Véronique Della-Valle; Françoise Picard; Franck Viguié; Bruno Quesnel; Odile Beyne-Rauzy; Eric Solary; Norbert Vey; Mathilde Hunault-Berger; Pierre Fenaux; Véronique Mansat-De Mas; Eric Delabesse; Philippe Guardiola; Catherine Lacombe; William Vainchenker; Claude Preudhomme; François Dreyfus; Olivier A Bernard; Daniel Birnbaum; Michaëla Fontenay
Journal:  Blood       Date:  2009-08-07       Impact factor: 22.113

5.  Distinct clinical outcomes for cytogenetic abnormalities evolving from aplastic anemia.

Authors:  Jaroslaw P Maciejewski; Antonio Risitano; Elaine M Sloand; Olga Nunez; Neal S Young
Journal:  Blood       Date:  2002-05-01       Impact factor: 22.113

6.  NRAS, FLT3 and TP53 mutations in patients with myelodysplastic syndrome and a del(5q).

Authors:  Carrie Fidler; Fiona Watkins; David T Bowen; Timothy J Littlewood; James S Wainscoat; Jacqueline Boultwood
Journal:  Haematologica       Date:  2004-07       Impact factor: 9.941

7.  Risk factors for evolution of acquired aplastic anemia into myelodysplastic syndrome and acute myeloid leukemia after immunosuppressive therapy in children.

Authors:  Seiji Kojima; Akira Ohara; Masahiro Tsuchida; Toru Kudoh; Ryoji Hanada; Yuri Okimoto; Takashi Kaneko; Toshikuni Takano; Koichiro Ikuta; Ichiro Tsukimoto
Journal:  Blood       Date:  2002-08-01       Impact factor: 22.113

Review 8.  Aplastic anemia: pathophysiology and treatment.

Authors:  Neal S Young; Andrea Bacigalupo; Judith C W Marsh
Journal:  Biol Blood Marrow Transplant       Date:  2009-09-24       Impact factor: 5.742

9.  Mutation in TET2 in myeloid cancers.

Authors:  François Delhommeau; Sabrina Dupont; Véronique Della Valle; Chloé James; Severine Trannoy; Aline Massé; Olivier Kosmider; Jean-Pierre Le Couedic; Fabienne Robert; Antonio Alberdi; Yann Lécluse; Isabelle Plo; François J Dreyfus; Christophe Marzac; Nicole Casadevall; Catherine Lacombe; Serge P Romana; Philippe Dessen; Jean Soulier; Franck Viguié; Michaela Fontenay; William Vainchenker; Olivier A Bernard
Journal:  N Engl J Med       Date:  2009-05-28       Impact factor: 91.245

Review 10.  Novel mutations and their functional and clinical relevance in myeloproliferative neoplasms: JAK2, MPL, TET2, ASXL1, CBL, IDH and IKZF1.

Authors:  A Tefferi
Journal:  Leukemia       Date:  2010-04-29       Impact factor: 11.528
View more
  16 in total

1.  Genetic predisposition to myelodysplastic syndrome and acute myeloid leukemia in children and young adults.

Authors:  Daria V Babushok; Monica Bessler; Timothy S Olson
Journal:  Leuk Lymphoma       Date:  2015-12-23

Review 2.  A brief, but comprehensive, guide to clonal evolution in aplastic anemia.

Authors:  Daria V Babushok
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

Review 3.  Diagnosis and Treatment of Aplastic Anemia.

Authors:  Scott A Peslak; Timothy Olson; Daria V Babushok
Journal:  Curr Treat Options Oncol       Date:  2017-11-16

Review 4.  Hematopoietic stem cell transplantation for acquired aplastic anemia.

Authors:  George E Georges; Rainer Storb
Journal:  Curr Opin Hematol       Date:  2016-11       Impact factor: 3.284

Review 5.  Recent advances in understanding clonal haematopoiesis in aplastic anaemia.

Authors:  Natasha Stanley; Timothy S Olson; Daria V Babushok
Journal:  Br J Haematol       Date:  2017-01-20       Impact factor: 6.998

6.  Secondary myelodysplastic syndrome and leukemia in acquired aplastic anemia and paroxysmal nocturnal hemoglobinuria.

Authors:  Lova Sun; Daria V Babushok
Journal:  Blood       Date:  2020-07-02       Impact factor: 22.113

Review 7.  Clonal hematopoiesis in acquired aplastic anemia.

Authors:  Seishi Ogawa
Journal:  Blood       Date:  2016-04-27       Impact factor: 22.113

8.  Detectable mutations precede late myeloid neoplasia in aplastic anemia.

Authors:  Bhavisha A Patel; Jack Ghannam; Emma M Groarke; Meghali Goswami; Laura Dillon; Fernanda Gutierrez-Rodrigues; Olga Rios; Diego Quinones Raffo; Jennifer Lotter; Neal S Young; Christopher S Hourigan
Journal:  Haematologica       Date:  2021-02-01       Impact factor: 9.941

9.  Somatic HLA Mutations Expose the Role of Class I-Mediated Autoimmunity in Aplastic Anemia and its Clonal Complications.

Authors:  Daria V Babushok; Jamie L Duke; Hongbo M Xie; Natasha Stanley; Jamie Atienza; Nieves Perdigones; Peter Nicholas; Deborah Ferriola; Yimei Li; Hugh Huang; Wenda Ye; Jennifer J D Morrissette; Jane Kearns; David L Porter; Gregory M Podsakoff; Laurence C Eisenlohr; Jaclyn A Biegel; Stella T Chou; Dimitrios S Monos; Monica Bessler; Timothy S Olson
Journal:  Blood Adv       Date:  2017-10-10

Review 10.  Severe aplastic anemia: allogeneic bone marrow transplantation as first-line treatment.

Authors:  George E Georges; Kris Doney; Rainer Storb
Journal:  Blood Adv       Date:  2018-08-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.